Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Mitochondrial hypoxic stress induces widespread RNA editing by APOBEC3G in natural killer cells.

Sharma S, Wang J, Alqassim E, Portwood S, Cortes Gomez E, Maguire O, Basse PH, Wang ES, Segal BH, Baysal BE.

Genome Biol. 2019 Feb 21;20(1):37. doi: 10.1186/s13059-019-1651-1.

2.

Stem-loop structure preference for site-specific RNA editing by APOBEC3A and APOBEC3G.

Sharma S, Baysal BE.

PeerJ. 2017 Dec 6;5:e4136. doi: 10.7717/peerj.4136. eCollection 2017.

3.

RNA Editing in Pathogenesis of Cancer.

Baysal BE, Sharma S, Hashemikhabir S, Janga SC.

Cancer Res. 2017 Jul 15;77(14):3733-3739. doi: 10.1158/0008-5472.CAN-17-0520. Epub 2017 Jun 30. Review.

4.

Mitochondrial complex II regulates a distinct oxygen sensing mechanism in monocytes.

Sharma S, Wang J, Cortes Gomez E, Taggart RT, Baysal BE.

Hum Mol Genet. 2017 Apr 1;26(7):1328-1339. doi: 10.1093/hmg/ddx041.

5.

The double-domain cytidine deaminase APOBEC3G is a cellular site-specific RNA editing enzyme.

Sharma S, Patnaik SK, Taggart RT, Baysal BE.

Sci Rep. 2016 Dec 15;6:39100. doi: 10.1038/srep39100.

6.

Transient overexpression of exogenous APOBEC3A causes C-to-U RNA editing of thousands of genes.

Sharma S, Patnaik SK, Kemer Z, Baysal BE.

RNA Biol. 2017 May 4;14(5):603-610. doi: 10.1080/15476286.2016.1184387. Epub 2016 May 5.

7.

15 YEARS OF PARAGANGLIOMA: Genetics and mechanism of pheochromocytoma-paraganglioma syndromes characterized by germline SDHB and SDHD mutations.

Baysal BE, Maher ER.

Endocr Relat Cancer. 2015 Aug;22(4):T71-82. doi: 10.1530/ERC-15-0226. Epub 2015 Jun 25. Review.

PMID:
26113606
8.

APOBEC3A cytidine deaminase induces RNA editing in monocytes and macrophages.

Sharma S, Patnaik SK, Taggart RT, Kannisto ED, Enriquez SM, Gollnick P, Baysal BE.

Nat Commun. 2015 Apr 21;6:6881. doi: 10.1038/ncomms7881.

9.

Hypoxia-inducible C-to-U coding RNA editing downregulates SDHB in monocytes.

Baysal BE, De Jong K, Liu B, Wang J, Patnaik SK, Wallace PK, Taggart RT.

PeerJ. 2013 Sep 10;1:e152. doi: 10.7717/peerj.152. eCollection 2013.

10.

Genotype and tumor locus determine expression profile of pseudohypoxic pheochromocytomas and paragangliomas.

Shankavaram U, Fliedner SM, Elkahloun AG, Barb JJ, Munson PJ, Huynh TT, Matro JC, Turkova H, Linehan WM, Timmers HJ, Tischler AS, Powers JF, de Krijger R, Baysal BE, Takacova M, Pastorekova S, Gius D, Lehnert H, Camphausen K, Pacak K.

Neoplasia. 2013 Apr;15(4):435-47.

11.

Mitochondrial complex II and genomic imprinting in inheritance of paraganglioma tumors.

Baysal BE.

Biochim Biophys Acta. 2013 May;1827(5):573-7. doi: 10.1016/j.bbabio.2012.12.005. Epub 2013 Jan 2. Review.

12.

Genomic imprinting at a boundary element flanking the SDHD locus.

Baysal BE, McKay SE, Kim YJ, Zhang Z, Alila L, Willett-Brozick JE, Pacak K, Kim TH, Shadel GS.

Hum Mol Genet. 2011 Nov 15;20(22):4452-61. doi: 10.1093/hmg/ddr376. Epub 2011 Aug 23.

13.

Revisiting the TCA cycle: signaling to tumor formation.

Raimundo N, Baysal BE, Shadel GS.

Trends Mol Med. 2011 Nov;17(11):641-9. doi: 10.1016/j.molmed.2011.06.001. Epub 2011 Jul 20. Review.

14.

Identification of a 4.9-kilo base-pair Alu-mediated founder SDHD deletion in two extended paraganglioma families from Austria.

Janecke AR, Willett-Brozick JE, Karas C, Hasipek M, Loeffler-Ragg J, Baysal BE.

J Hum Genet. 2010 Mar;55(3):182-5. doi: 10.1038/jhg.2009.142. Epub 2010 Jan 29.

PMID:
20111059
15.

Screening: Correlation of genotype and phenotype in paraganglioma.

Baysal BE.

Nat Rev Endocrinol. 2009 Nov;5(11):594-5. doi: 10.1038/nrendo.2009.202. No abstract available.

PMID:
19844247
16.

Clinical and molecular progress in hereditary paraganglioma.

Baysal BE.

J Med Genet. 2008 Nov;45(11):689-94. doi: 10.1136/jmg.2008.058560. Review.

PMID:
18978332
17.

Biochemically silent abdominal paragangliomas in patients with mutations in the succinate dehydrogenase subunit B gene.

Timmers HJ, Pacak K, Huynh TT, Abu-Asab M, Tsokos M, Merino MJ, Baysal BE, Adams KT, Eisenhofer G.

J Clin Endocrinol Metab. 2008 Dec;93(12):4826-32. doi: 10.1210/jc.2008-1093. Epub 2008 Oct 7.

18.

Relationship between ERCC1 polymorphisms, disease progression, and survival in the Gynecologic Oncology Group Phase III Trial of intraperitoneal versus intravenous cisplatin and paclitaxel for stage III epithelial ovarian cancer.

Krivak TC, Darcy KM, Tian C, Armstrong D, Baysal BE, Gallion H, Ambrosone CB, DeLoia JA; Gynecologic Oncology Group Phase III Trial.

J Clin Oncol. 2008 Jul 20;26(21):3598-606. doi: 10.1200/JCO.2008.16.1323.

20.

Screening for familial paragangliomas.

Myssiorek D, Ferlito A, Silver CE, Rodrigo JP, Baysal BE, Fagan JJ, Suárez C, Rinaldo A.

Oral Oncol. 2008 Jun;44(6):532-7. Epub 2007 Nov 1. Review.

PMID:
17936061
21.

Genetics of carney triad: recurrent losses at chromosome 1 but lack of germline mutations in genes associated with paragangliomas and gastrointestinal stromal tumors.

Matyakhina L, Bei TA, McWhinney SR, Pasini B, Cameron S, Gunawan B, Stergiopoulos SG, Boikos S, Muchow M, Dutra A, Pak E, Campo E, Cid MC, Gomez F, Gaillard RC, Assie G, Füzesi L, Baysal BE, Eng C, Carney JA, Stratakis CA.

J Clin Endocrinol Metab. 2007 Aug;92(8):2938-43. Epub 2007 May 29.

PMID:
17535989
22.

Loss of distal 11q is associated with DNA repair deficiency and reduced sensitivity to ionizing radiation in head and neck squamous cell carcinoma.

Parikh RA, White JS, Huang X, Schoppy DW, Baysal BE, Baskaran R, Bakkenist CJ, Saunders WS, Hsu LC, Romkes M, Gollin SM.

Genes Chromosomes Cancer. 2007 Aug;46(8):761-75.

PMID:
17492757
24.
25.

Role of mitochondrial mutations in cancer.

Baysal BE.

Endocr Pathol. 2006 Fall;17(3):203-12. Review.

PMID:
17308357
26.

A phenotypic perspective on Mammalian oxygen sensor candidates.

Baysal BE.

Ann N Y Acad Sci. 2006 Aug;1073:221-33. Review.

PMID:
17102090
27.

Common variations in ALG9 are not associated with bipolar I disorder: a family-based study.

Baysal BE, Willett-Brozick JE, Bacanu SA, Detera-Wadleigh S, Nimgaonkar VL.

Behav Brain Funct. 2006 Jul 21;2:25.

28.

Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene.

Schiavi F, Boedeker CC, Bausch B, Peçzkowska M, Gomez CF, Strassburg T, Pawlu C, Buchta M, Salzmann M, Hoffmann MM, Berlis A, Brink I, Cybulla M, Muresan M, Walter MA, Forrer F, Välimäki M, Kawecki A, Szutkowski Z, Schipper J, Walz MK, Pigny P, Bauters C, Willet-Brozick JE, Baysal BE, Januszewicz A, Eng C, Opocher G, Neumann HP; European-American Paraganglioma Study Group.

JAMA. 2005 Oct 26;294(16):2057-63. Erratum in: JAMA. 2006 Feb 8;295(6):628.

PMID:
16249420
29.

High-resolution methylation analysis of the BRCA1 promoter in ovarian tumors.

Wilcox CB, Baysal BE, Gallion HH, Strange MA, DeLoia JA.

Cancer Genet Cytogenet. 2005 Jun;159(2):114-22.

PMID:
15899382
30.

Analysis of CHEK2 gene for ovarian cancer susceptibility.

Baysal BE, DeLoia JA, Willett-Brozick JE, Goodman MT, Brady MF, Modugno F, Lynch HT, Conley YP, Watson P, Gallion HH.

Gynecol Oncol. 2004 Oct;95(1):62-9.

PMID:
15385111
31.

An Alu-mediated partial SDHC deletion causes familial and sporadic paraganglioma.

Baysal BE, Willett-Brozick JE, Filho PA, Lawrence EC, Myers EN, Ferrell RE.

J Med Genet. 2004 Sep;41(9):703-9. No abstract available. Erratum in: J Med Genet. 2005 Jul;42(7):582.

32.

Genomic imprinting and environment in hereditary paraganglioma.

Baysal BE.

Am J Med Genet C Semin Med Genet. 2004 Aug 15;129C(1):85-90. Review.

PMID:
15264276
33.

On the association of succinate dehydrogenase mutations with hereditary paraganglioma.

Baysal BE.

Trends Endocrinol Metab. 2003 Dec;14(10):453-9. Review.

PMID:
14643060
34.

Altitude is a phenotypic modifier in hereditary paraganglioma type 1: evidence for an oxygen-sensing defect.

Astrom K, Cohen JE, Willett-Brozick JE, Aston CE, Baysal BE.

Hum Genet. 2003 Aug;113(3):228-37. Epub 2003 Jun 17.

PMID:
12811540
35.

Etiopathogenesis and clinical presentation of carotid body tumors.

Baysal BE, Myers EN.

Microsc Res Tech. 2002 Nov 1;59(3):256-61. Review.

PMID:
12384970
36.
37.

Hereditary paraganglioma targets diverse paraganglia.

Baysal BE.

J Med Genet. 2002 Sep;39(9):617-22. Review.

38.

A mannosyltransferase gene at 11q23 is disrupted by a translocation breakpoint that co-segregates with bipolar affective disorder in a small family.

Baysal BE, Willett-Brozick JE, Badner JA, Corona W, Ferrell RE, Nimgaonkar VL, Detera-Wadleigh SD.

Neurogenetics. 2002 Mar;4(1):43-53.

PMID:
12030331
39.

Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas.

Baysal BE, Willett-Brozick JE, Lawrence EC, Drovdlic CM, Savul SA, McLeod DR, Yee HA, Brackmann DE, Slattery WH 3rd, Myers EN, Ferrell RE, Rubinstein WS.

J Med Genet. 2002 Mar;39(3):178-83.

40.

Proportion of heritable paraganglioma cases and associated clinical characteristics.

Drovdlic CM, Myers EN, Peters JA, Baysal BE, Brackmann DE, Slattery WH 3rd, Rubinstein WS.

Laryngoscope. 2001 Oct;111(10):1822-7.

PMID:
11801952
41.

Phenotypic dichotomy in mitochondrial complex II genetic disorders.

Baysal BE, Rubinstein WS, Taschner PE.

J Mol Med (Berl). 2001 Sep;79(9):495-503. Review.

PMID:
11692162
42.

Genetics of familial paragangliomas: past, present, and future.

Baysal BE.

Otolaryngol Clin North Am. 2001 Oct;34(5):863-79, vi. Review.

PMID:
11557444
43.

Germ line insertion of mtDNA at the breakpoint junction of a reciprocal constitutional translocation.

Willett-Brozick JE, Savul SA, Richey LE, Baysal BE.

Hum Genet. 2001 Aug;109(2):216-23.

PMID:
11511928
44.

Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene.

Taschner PE, Jansen JC, Baysal BE, Bosch A, Rosenberg EH, Bröcker-Vriends AH, van Der Mey AG, van Ommen GJ, Cornelisse CJ, Devilee P.

Genes Chromosomes Cancer. 2001 Jul;31(3):274-81.

PMID:
11391798
45.

Novel mutations in the SDHD gene in pedigrees with familial carotid body paraganglioma and sensorineural hearing loss.

Badenhop RF, Cherian S, Lord RS, Baysal BE, Taschner PE, Schofield PR.

Genes Chromosomes Cancer. 2001 Jul;31(3):255-63.

PMID:
11391796
46.
47.

Genetic analysis in the diagnosis of familial paragangliomas.

Petropoulos AE, Luetje CM, Camarata PJ, Whittaker CK, Lee G, Baysal BE.

Laryngoscope. 2000 Jul;110(7):1225-9.

PMID:
10892701
48.

Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma.

Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, Bosch A, van der Mey A, Taschner PE, Rubinstein WS, Myers EN, Richard CW 3rd, Cornelisse CJ, Devilee P, Devlin B.

Science. 2000 Feb 4;287(5454):848-51.

49.

Genomic structure of the human PLZF gene.

van Schothorst EM, Prins DE, Baysal BE, Beekman M, Licht JD, Waxman S, Zelent A, Cornelisse CJ, van Ommen GJ, Richard CW 3rd, Devilee P.

Gene. 1999 Aug 5;236(1):21-4.

PMID:
10433962
50.

Fine mapping of the split-hand/split-foot locus (SHFM3) at 10q24: evidence for anticipation and segregation distortion.

Ozen RS, Baysal BE, Devlin B, Farr JE, Gorry M, Ehrlich GD, Richard CW.

Am J Hum Genet. 1999 Jun;64(6):1646-54.

Supplemental Content

Loading ...
Support Center